EPAS1 and pulmonary arterial hypertension: In contrast, patients with gain-of-function HIF-2α mutations have a more restricted cardiopulmonary phenotype of pulmonary hypertension and exaggerated pulmonary vascular responses to acute hypoxia (23, 25).